DOSIMETRY/VALIDATION STUDY OF 131IODINE-ANTI B1 (MURINE) RADIOIMMUNOTHERAPY FOR CHEMOTHERAPY REFRACTORY LOW GRADE B CELL LYMPHOMAS AND LOW GRADE LYMPHOMAS THAT HAVE TRANSFORMED TO HIGHER GRADE HISTOLOGIES: